An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada

Por Rotstein, Coleman, Laverdière, Michel, Marciniak, Anne, Ali, Farzad
Publicado em 2004

Choices, persistence and adherence to antihypertensive agents: Evidence from RAMQ data

Por Lachaine, Jean, Petrella, Robert J, Merikle, Elizabeth, Ali, Farzad
Publicado em 2008

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug

Por Guertin, Jason R, Mitchell, Dominic, Ali, Farzad, LeLorier, Jacques
Publicado no Clinicoecon Outcomes Res (2015)